Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-555
Closed -$301 3479
2023
Q2
$301 Hold
555
﹤0.01% 3270
2023
Q1
$1.58K Sell
555
-229
-29% -$250 ﹤0.01% 2969
2022
Q4
$5K Sell
784
-281
-26% -$438 ﹤0.01% 3798
2022
Q3
$5K Buy
1,065
+25
+2% +$62 ﹤0.01% 4046
2022
Q2
$4K Hold
1,040
﹤0.01% 3905
2022
Q1
$4K Buy
1,040
+485
+87% +$1.7K ﹤0.01% 3904
2021
Q4
$3K Hold
555
﹤0.01% 2681
2021
Q3
$4K Hold
555
﹤0.01% 2648
2021
Q2
$4K Sell
555
-575
-51% -$4.85K ﹤0.01% 2559
2021
Q1
$8K Buy
1,130
+375
+50% +$2.49K ﹤0.01% 2233
2020
Q4
$1K Buy
+755
New +$364 ﹤0.01% 2795

Other funds holding OCGN

IFP Advisors's OCGN Position: Q3 2023 in Review

IFP Advisors sold out of Ocugen (OCGN) in Q3 2023, closing a stake of 555 shares — an estimated $301 sold.

IFP Advisors first reported a position in OCGN in Q4 2020 and held it in 11 quarters. The position peaked at $8K in Q1 2021. 78 funds tracked by Wall St. Rank hold OCGN as of Q3 2023.

  • IFP Advisors reported no remaining Ocugen position as of Q3 2023 after selling out during the quarter.
  • IFP Advisors sold 555 Ocugen shares in Q3 2023, an estimated $301.
  • IFP Advisors first reported a position in Ocugen in Q4 2020 and held it in 11 quarters.
  • IFP Advisors's Ocugen position peaked at $8K in Q1 2021.
  • 78 funds tracked by Wall St. Rank held Ocugen as of Q3 2023.

Based on IFP Advisors's 13F filing for Q3 2023, filed 12 Oct 2023.